Papers - SATO Yoshitaka
-
Initial Characterization of the Epstein-Barr Virus BSRF1 Gene Product Reviewed International journal
Yanagi Yusuke, Al Masud H. M. Abdullah, Watanabe Takahiro, Sato Yoshitaka, Goshima Fumi, Kimura Hiroshi, Murata Takayuki
VIRUSES-BASEL Vol. 11 ( 3 ) 2019.3
-
Defective Epstein-Barr virus in chronic active infection and haematological malignancy. Reviewed International journal
Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H
Nature microbiology Vol. 4 ( 3 ) page： 404 - 413 2019.3
-
Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases Reviewed International journal
Sato Yoshitaka
FRONTIERS IN PEDIATRICS Vol. 6 page： 320 2018.11
-
Regulation of Epstein-Barr Virus Life Cycle and Cell Proliferation by Histone H3K27 Methyltransferase EZH2 in Akata Cells Reviewed International journal
Ichikawa Takaya, Okuno Yusuke, Sato Yoshitaka, Goshima Fumi, Yoshiyama Hironori, Kanda Teru, Kimura Hiroshi, Murata Takayuki
MSPHERE Vol. 3 ( 6 ) 2018.11
-
Antitumor effects of duvelisib on Epstein-Barr virus-associated lymphoma cells. Reviewed International journal
Kawada JI, Ando S, Torii Y, Watanabe T, Sato Y, Ito Y, Kimura H
Cancer medicine Vol. 7 ( 4 ) page： 1275 - 1284 2018.4
-
BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection Reviewed International journal
Konishi Natsuno, Narita Yohei, Hijioka Fumiya, Al Masud H. M. Abdullah, Sato Yoshitaka, Kimura Hiroshi, Murata Takayuki
MSPHERE Vol. 3 ( 2 ) 2018.3
-
Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production. Reviewed International journal
Masud HMAA, Watanabe T, Yoshida M, Sato Y, Goshima F, Kimura H, Murata T
Journal of virology Vol. 91 ( 23 ) 2017.12
-
Characterization of a Suppressive <i>Cis</i>-acting Element in the Epstein-Barr Virus LMP1 Promoter. Reviewed International journal
Yoshida M, Murata T, Ashio K, Narita Y, Watanabe T, Masud HMAA, Sato Y, Goshima F, Kimura H
Frontiers in microbiology Vol. 8 page： 2302 2017.11
-
The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation. Reviewed International journal
Yoshida M, Watanabe T, Narita Y, Sato Y, Goshima F, Kimura H, Murata T
Scientific reports Vol. 7 ( 1 ) page： 6044 2017.7
-
Elimination of LMP1-expressing cells from a monolayer of gastric cancer AGS cells. Reviewed International journal
Sato Y, Ochiai S, Murata T, Kanda T, Goshima F, Kimura H
Oncotarget Vol. 8 ( 24 ) page： 39345 - 39355 2017.6
-
The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production. Reviewed International journal
Watanabe T, Sakaida K, Yoshida M, Masud HM, Sato Y, Goshima F, Kimura H, Murata T
Frontiers in microbiology Vol. 8 page： 125 2017.1
-
The efficacy of combination therapy with oncolytic herpes simplex virus HF10 and dacarbazine in a mouse melanoma model. Reviewed
Tanaka R, Goshima F, Esaki S, Sato Y, Murata T, Nishiyama Y, Watanabe D, Kimura H
American journal of cancer research Vol. 7 ( 8 ) page： 1693 - 1703 2017
-
The efficacy of combination therapy with oncolytic herpes simplex virus HF10 and dacarbazine in a mouse melanoma model Reviewed
Tanaka Rui, Goshima Fumi, Esaki Shinichi, Sato Yoshitaka, Murata Takayuki, Nishiyama Yukihiro, Watanabe Daisuke, Kimura Hiroshi
AMERICAN JOURNAL OF CANCER RESEARCH Vol. 7 ( 8 ) page： 1693-1703 2017
-
Tofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells. Reviewed
Ando S, Kawada JI, Watanabe T, Suzuki M, Sato Y, Torii Y, Asai M, Goshima F, Murata T, Shimizu N, Ito Y, Kimura H
Oncotarget Vol. 7 ( 47 ) page： 76793-76805 2016.11
-
Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor. Reviewed
Murata T, Noda C, Narita Y, Watanabe T, Yoshida M, Ashio K, Sato Y, Goshima F, Kanda T, Yoshiyama H, Tsurumi T, Kimura H
Journal of virology Vol. 90 ( 8 ) page： 3873-89 2016.4
-
Induction of Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (LMP1) by Transcription Factors Activating Protein 2 (AP-2) and Early B Cell Factor (EBF) Reviewed
Takayuki Murata, Chieko Noda, Yohei Narita, Takahiro Watanabe, Masahiro Yoshida, Keiji Ashio, Yoshitaka Sato, Fumi Goshima, Teru Kanda, Hironori Yoshiyama, Tatsuya Tsurumi, and Hiroshi Kimura
Journal of Virology Vol. 90 page： 3873-3889 2016
-
The Epstein-Barr Virus BDLF4 Gene Is Required for Efficient Expression of Viral Late Lytic Genes. Reviewed
Watanabe T, Narita Y, Yoshida M, Sato Y, Goshima F, Kimura H, Murata T
Journal of virology Vol. 89 ( 19 ) page： 10120-4 2015.10
-
Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases. Reviewed
Kanazawa T, Hiramatsu Y, Iwata S, Siddiquey M, Sato Y, Suzuki M, Ito Y, Goshima F, Murata T, Kimura H
Clinical cancer research : an official journal of the American Association for Cancer Research Vol. 20 ( 19 ) page： 5075-84 2014.10
-
Role of latent membrane protein 1 in chronic active Epstein-Barr virus infection-derived T/NK-cell proliferation. Reviewed
Ito T, Kawazu H, Murata T, Iwata S, Arakawa S, Sato Y, Kuzushima K, Goshima F, Kimura H
Cancer medicine Vol. 3 ( 4 ) page： 787-95 2014.8
-
Modes of infection and oncogenesis by the Epstein-Barr virus. Reviewed
Murata T, Sato Y, Kimura H
Reviews in medical virology Vol. 24 ( 4 ) page： 242-53 2014.7